Test to Treatment - Navigating Positive Blood Culture Syndromic Testing Outcomes

Explore how syndromic testing is revolutionizing the diagnostic and clinical management of bloodstream infections through this innovation-focused webinar featuring real-world insights from the Medical College of Wisconsin. Learn from Nathan Ledeboer, Chief of Clinical Pathology, as he demonstrates how multiplex syndromic testing accelerates time to diagnosis and guides effective treatment decisions for bloodstream infections and sepsis management. Discover the impact of rapid, multiplex syndromic testing on patient outcomes through detailed case studies and clinical data, while understanding how positive blood culture results are interpreted and acted upon in real clinical workflows. Examine the critical role of molecular diagnostics in antimicrobial stewardship and sepsis management, with particular focus on identifying diagnostic limitations in current BSI management, including gaps in resistance gene detection and challenges with fixed molecular panels. Evaluate the clinical impact of expanded resistance gene coverage, including detection of emerging threats like SME and MCR, and learn how this supports timely therapeutic decisions. Investigate real-world scenarios where syndromic testing enhances antimicrobial stewardship through CRE surveillance, therapy de-escalation, and alignment with antimicrobial stewardship program protocols, while reviewing the overall performance of the LIAISON PLEX® BSI system. This comprehensive session targets laboratory professionals, infectious disease specialists, and healthcare leaders seeking to optimize their approach to BSI and sepsis diagnostics with advanced, actionable diagnostic tools.